Update on vascular catheter infections

被引:9
作者
Sherertz, RJ [1 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Med, Infect Dis Sect, Winston Salem, NC 27157 USA
关键词
infection; prevention; randomized trial; treatment; vascular catheter;
D O I
10.1097/01.qco.0000136925.52673.16
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review Extensive reviews of our current understanding of vascular catheter infections have recently been published. This update highlights 22 primary research articles selected from 415 randomized clinical trials and over 2500 other articles on vascular catheter infections published between January 2002 and March 2004. Recent findings Full sterile barriers are not necessary for the insertion of arterial catheters. Subcutaneous tunnels may decrease the risk of femoral catheter infection. The minocycline-rifampin catheter coating still appears to be the most efficacious. Further studies demonstrating that education of MD/RN personnel reduces the risk of catheter infection now exist. A number of studies show that the method of attaching IV tubing to catheters and certain catheter flush solutions can reduce the risk of infection. Differential time to positivity looks increasingly promising as a practical method for diagnosing catheter infection. All catheters suspected of infection do not need to be removed. The management of vascular catheter infections can be improved by a simple e-mail mechanism. Summary Abundant evidence now exists that there are many interventions that can reduce the risk of vascular catheter infections. The next phase of our understanding should include determining how many of these many interventions are necessary and under what circumstances.
引用
收藏
页码:303 / 307
页数:5
相关论文
共 31 条
[1]   A prospective double-blind randomized trial of urokinase flushes to prevent bacteremia resulting from luminal colonization of subcutaneous central venous catheters [J].
Aquino, VM ;
Sandler, ES ;
Mustafa, MM ;
Steele, JW ;
Buchanan, GR .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (09) :710-713
[2]   Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters: a randomised controlled trial [J].
Bong, JJ ;
Kite, P ;
Wilco, MH ;
McMahon, MJ .
JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (10) :731-735
[3]   A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow® needleless connector [J].
Casey, AL ;
Worthington, T ;
Lambert, PA ;
Quinn, D ;
Faroqui, MH ;
Elliott, TSJ .
JOURNAL OF HOSPITAL INFECTION, 2003, 54 (04) :288-293
[4]   Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer [J].
Chatzinikolaou, I ;
Zipf, TF ;
Hanna, H ;
Umphrey, J ;
Roberts, WM ;
Sherertz, R ;
Hachem, R ;
Raad, I .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :116-119
[5]   Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: A prospective, randomized study [J].
Chatzinikolaou, L ;
Finkel, K ;
Hanna, H ;
Boktour, M ;
Foringer, J ;
Ho, T ;
Raad, I .
AMERICAN JOURNAL OF MEDICINE, 2003, 115 (05) :352-357
[6]   Comparison between replacement at 4 days and 7 days of the infection rate for pulmonary artery catheters in an intensive care unit [J].
Chen, YY ;
Yen, DHT ;
Yang, YG ;
Liu, CY ;
Wang, FD ;
Chou, P .
CRITICAL CARE MEDICINE, 2003, 31 (05) :1353-1358
[7]   A CONTROLLED TRIAL OF SCHEDULED REPLACEMENT OF CENTRAL VENOUS AND PULMONARY-ARTERY CATHETERS [J].
COBB, DK ;
HIGH, KP ;
SAWYER, RG ;
SABLE, CA ;
ADAMS, RB ;
LINDLEY, DA ;
PRUETT, TL ;
SCHWENZER, KJ ;
FARR, BM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (15) :1062-1068
[8]   Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections [J].
Curtin, J ;
Cormican, M ;
Fleming, G ;
Keelehan, J ;
Colleran, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3145-3148
[9]   Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter [J].
Dannenberg, C ;
Bierbach, U ;
Rothe, A ;
Beer, J ;
Körholz, D .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (08) :616-621
[10]   A comparison of two antimicrobial-impregnated central venous catheters [J].
Darouiche, RO ;
Raad, II ;
Heard, SO ;
Thornby, JI ;
Wenker, OC ;
Gabrielli, A ;
Berg, J ;
Khardori, N ;
Hanna, H ;
Hachem, R ;
Harris, RL ;
Mayhall, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (01) :1-8